Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η

Cytarabine (AraC) is the mainstay chemotherapy for acute myeloid leukemia (AML). Whereas initial treatment with AraC is usually successful, most AML patients tend to relapse, and AraC treatment-induced mutagenesis may contribute to the development of chemo-resistant leukemic clones. We show here tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Rechkoblit, Olga, Johnson, Robert E., Buku, Angeliki, Prakash, Louise, Prakash, Satya, Aggarwal, Aneel K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6841716/
https://www.ncbi.nlm.nih.gov/pubmed/31704958
http://dx.doi.org/10.1038/s41598-019-52703-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6841716/
https://www.ncbi.nlm.nih.gov/pubmed/31704958
http://dx.doi.org/10.1038/s41598-019-52703-7

Ejemplares similares